514 related articles for article (PubMed ID: 29872621)
1. Biomacromolecules as carriers in drug delivery and tissue engineering.
Zhang Y; Sun T; Jiang C
Acta Pharm Sin B; 2018 Jan; 8(1):34-50. PubMed ID: 29872621
[TBL] [Abstract][Full Text] [Related]
2. The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment.
Yang M; Li J; Gu P; Fan X
Bioact Mater; 2021 Jul; 6(7):1973-1987. PubMed ID: 33426371
[TBL] [Abstract][Full Text] [Related]
3. Carbon nanotubes for delivery of small molecule drugs.
Wong BS; Yoong SL; Jagusiak A; Panczyk T; Ho HK; Ang WH; Pastorin G
Adv Drug Deliv Rev; 2013 Dec; 65(15):1964-2015. PubMed ID: 23954402
[TBL] [Abstract][Full Text] [Related]
4. Advanced application of stimuli-responsive drug delivery system for inflammatory arthritis treatment.
Zhang M; Hu W; Cai C; Wu Y; Li J; Dong S
Mater Today Bio; 2022 Mar; 14():100223. PubMed ID: 35243298
[TBL] [Abstract][Full Text] [Related]
5. Bioresponsive functional nanogels as an emerging platform for cancer therapy.
Huang D; Qian H; Qiao H; Chen W; Feijen J; Zhong Z
Expert Opin Drug Deliv; 2018 Jul; 15(7):703-716. PubMed ID: 29976103
[TBL] [Abstract][Full Text] [Related]
6. Biological drug and drug delivery-mediated immunotherapy.
Xiao Q; Li X; Li Y; Wu Z; Xu C; Chen Z; He W
Acta Pharm Sin B; 2021 Apr; 11(4):941-960. PubMed ID: 33996408
[TBL] [Abstract][Full Text] [Related]
7. Nanoparticles design considerations to co-deliver nucleic acids and anti-cancer drugs for chemoresistance reversal.
Eljack S; David S; Faggad A; Chourpa I; Allard-Vannier E
Int J Pharm X; 2022 Dec; 4():100126. PubMed ID: 36147518
[TBL] [Abstract][Full Text] [Related]
8. Transformative hyaluronic acid-based active targeting supramolecular nanoplatform improves long circulation and enhances cellular uptake in cancer therapy.
Zhong L; Xu L; Liu Y; Li Q; Zhao D; Li Z; Zhang H; Zhang H; Kan Q; Wang Y; Sun J; He Z
Acta Pharm Sin B; 2019 Mar; 9(2):397-409. PubMed ID: 30972285
[TBL] [Abstract][Full Text] [Related]
9. A novel prototype of albumin nanoparticles fabricated by supramolecular cyclodextrin-adamantane association.
Lee S; Lee C; Kim B; Thao LQ; Lee ES; Kim JO; Oh KT; Choi HG; Youn YS
Colloids Surf B Biointerfaces; 2016 Nov; 147():281-290. PubMed ID: 27522557
[TBL] [Abstract][Full Text] [Related]
10. Role of integrated cancer nanomedicine in overcoming drug resistance.
Iyer AK; Singh A; Ganta S; Amiji MM
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
[TBL] [Abstract][Full Text] [Related]
11. Biomedical applications of chitosan/silk fibroin composites: A review.
Xing X; Han Y; Cheng H
Int J Biol Macromol; 2023 Jun; 240():124407. PubMed ID: 37060984
[TBL] [Abstract][Full Text] [Related]
12. Novel nano therapeutic materials for the effective treatment of rheumatoid arthritis-recent insights.
Janakiraman K; Krishnaswami V; Rajendran V; Natesan S; Kandasamy R
Mater Today Commun; 2018 Dec; 17():200-213. PubMed ID: 32289062
[TBL] [Abstract][Full Text] [Related]
13. Chondrogenic differentiation of rat MSCs on porous scaffolds of silk fibroin/chitosan blends.
Bhardwaj N; Kundu SC
Biomaterials; 2012 Apr; 33(10):2848-57. PubMed ID: 22261099
[TBL] [Abstract][Full Text] [Related]
14. Characterisation of the conjugate of the (6-maleimidocaproyl)hydrazone derivative of doxorubicin with lactosaminated human albumin by 13C NMR spectroscopy.
Boga C; Fiume L; Baglioni M; Bertucci C; Farina C; Kratz F; Manerba M; Naldi M; Di Stefano G
Eur J Pharm Sci; 2009 Oct; 38(3):262-9. PubMed ID: 19695327
[TBL] [Abstract][Full Text] [Related]
15. Surface functionalization of methotrexate-loaded chitosan nanoparticles with hyaluronic acid/human serum albumin: Comparative characterization and in vitro cytotoxicity.
Hashad RA; Ishak RA; Geneidi AS; Mansour S
Int J Pharm; 2017 Apr; 522(1-2):128-136. PubMed ID: 28279742
[TBL] [Abstract][Full Text] [Related]
16. Silk coatings on PLGA and alginate microspheres for protein delivery.
Wang X; Wenk E; Hu X; Castro GR; Meinel L; Wang X; Li C; Merkle H; Kaplan DL
Biomaterials; 2007 Oct; 28(28):4161-9. PubMed ID: 17583788
[TBL] [Abstract][Full Text] [Related]
17. Functional hepatocyte clusters on bioactive blend silk matrices towards generating bioartificial liver constructs.
Janani G; Nandi SK; Mandal BB
Acta Biomater; 2018 Feb; 67():167-182. PubMed ID: 29223705
[TBL] [Abstract][Full Text] [Related]
18. Spermine-modified Antheraea pernyi silk fibroin as a gene delivery carrier.
Yu Y; Hu Y; Li X; Liu Y; Li M; Yang J; Sheng W
Int J Nanomedicine; 2016; 11():1013-23. PubMed ID: 27042056
[TBL] [Abstract][Full Text] [Related]
19. Enhanced delivery of artemisinin and its analogues to cancer cells by their adducts with human serum transferrin.
Yang Y; Zhang X; Wang X; Zhao X; Ren T; Wang F; Yu B
Int J Pharm; 2014 Jun; 467(1-2):113-22. PubMed ID: 24661944
[TBL] [Abstract][Full Text] [Related]
20. Chemodrug delivery using integrin-targeted PLGA-Chitosan nanoparticle for lung cancer therapy.
Babu A; Amreddy N; Muralidharan R; Pathuri G; Gali H; Chen A; Zhao YD; Munshi A; Ramesh R
Sci Rep; 2017 Nov; 7(1):14674. PubMed ID: 29116098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]